Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2014 Apr 27;20:575–592.

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2014 Molecular Vision.

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited, used for non-commercial purposes, and is not altered or transformed.

PMC Copyright notice

Patient #5.Blue fundus autofluorescence (FAF) and spectral-domain optical coherence tomography (SD-OCT) reveal the right eye affected with atrophic lesion at both study entry and last follow-up visit (38 months later). At study entry (top left and bottom left panels), blue FAF frames show reduced autofluorescence (with some residual dispersed autofluorescent material), and SD-OCT shows atrophic changes (diffuse loss of photoreceptor and other sensory retina layers, with retinal pseudocysts [asterisk] and outer retinal tabulation [arrowhead]) within the area previously occupied by the yellowish material. Blue FAF and SD-OCT findings appear unchanged at the last follow-up visit (top right and bottom right panels). Note the presence of a hyperautofluorescent ring.